Tesamorelin or CJC-1295: what's the difference
Tesamorelin and CJC-1295: molecular structure, duration of action, evidence base and regulatory status of two growth hormone-releasing hormone analogues. An editorial breakdown.
Glovspot — a blog about training, nutrition and recovery
Latest posts
All
Tesamorelin vs CJC-1295: what to choose and for whom
Tesamorelin vs CJC-1295: who each peptide was studied for, which clinical situations lie behind the choice, why self-administration is risky. An editorial analysis.
Hexarelin or GHRP-6: what's the difference
Hexarelin and GHRP-6: a shared ghrelin receptor, differences in structure, strength of GH release, effect on appetite, cortisol, prolactin and the heart. An editorial review with sources.
Hexarelin vs GHRP-6: what to choose and for whom
Hexarelin vs GHRP-6: in which situations they were studied, why neither is a justified choice for healthy people and which approved ghrelin mimetics exist today.
BPC-157 or Collagen: what's the difference
BPC-157 and collagen: a peptide drug candidate versus a dietary protein. Mechanisms, level of evidence for tendons and joints, regulatory and anti-doping status.
BPC-157 vs Collagen: what to choose and for whom
BPC-157 vs collagen: what to choose for joint pain, tendinopathy or after an injury. Practical scenarios, how to take collagen according to the research, and why BPC-157 is not a choice.
TB-500 or BPC-157: what was studied for tendons
TB-500 or BPC-157 for tendons: which experiments were conducted, on which models, which mechanisms have been described and what is still lacking. An editorial review of the evidence.
TB-500 vs BPC-157: a comparison of study data
TB-500 vs BPC-157: a critical analysis of the studies - experimental design, independence of groups, human data, safety and gaps. How to read the scientific base of peptides.
Semaglutide or Metformin: what's the difference
Semaglutide and metformin: different mechanisms of action, effect on glucose, body weight and cardiovascular risks, side effects and forms of administration. A comparative editorial review.
Semaglutide vs Metformin: what to choose and for whom
Semaglutide vs metformin: which drug suits whom according to clinical guidelines - diabetes, prediabetes, obesity, cardiovascular risk; separately about athletes and 'cutting.'
Tesamorelin or CJC-1295: what's the difference
Tesamorelin and CJC-1295: molecular structure, duration of action, evidence base and regulatory status of two growth hormone-releasing hormone analogues. An editorial breakdown.
Tesamorelin vs CJC-1295: what to choose and for whom
Tesamorelin vs CJC-1295: who each peptide was studied for, which clinical situations lie behind the choice, why self-administration is risky. An editorial analysis.